Rong Hai, Ph.D.

2006 University of California, Berkeley, Berkeley, CA, United States 
Virology Biology
"Rong Hai"


Sign in to add mentor
Fenyong Liu grad student 2006 UC Berkeley
 (Functional investigation of US15 in human cytomegalovirus (HCMV) infection in retinal pigment epithelial (RPE) cells.)
Peter Palese post-doc 2007-2015 MSSM
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen G, Han Q, Li WX, et al. (2024) Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells. Proceedings of the National Academy of Sciences of the United States of America. 121: e2321170121
Dulin H, Barre RS, Xu D, et al. (2024) Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2. Journal of Virology. e0157123
Biswal M, Yao W, Lu J, et al. (2024) A conformational selection mechanism of flavivirus NS5 for species-specific STAT2 inhibition. Communications Biology. 7: 76
Chavez JR, Yao W, Dulin H, et al. (2023) Modeling the effects of cigarette smoke extract on influenza B virus infections in mice. Frontiers in Immunology. 14: 1083251
Dulin H, Hendricks N, Xu D, et al. (2022) Impact of Protein Nitration on Influenza Virus Infectivity and Immunogenicity. Microbiology Spectrum. e0190222
Wang A, Hai R, Rider PJ, et al. (2022) Noncoding RNAs and Deep Learning Neural Network Discriminate Multi-Cancer Types. Cancers. 14
Chavez J, Hai R. (2021) Effects of Cigarette Smoking on Influenza Virus/Host Interplay. Pathogens (Basel, Switzerland). 10
Carreño JM, Strohmeier S, Kirkpatrick Roubidoux E, et al. (2020) H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model. Mbio. 11
Wang B, Thurmond S, Zhou K, et al. (2020) Structural basis for STAT2 suppression by flavivirus NS5. Nature Structural & Molecular Biology
Bernstein DI, Guptill J, Naficy A, et al. (2019) Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. The Lancet. Infectious Diseases
See more...